Telix Buys U.S. Radiopharmacy Network RLS for $230 Million
Telix Pharmaceuticals announced that it has agreed to buy RLS from its parent company, RLS Group. The acquisition of RLS will expand Telix’s North American manufacturing and distribution platform. Kirkland & Ellis acted as advisor to RLS in the transaction. RLS is America’s only Joint Commission-accredited radiopharmacy network, with 31 radiopharmacies covering more than 85% of the population. RLS’ revenue for FY 2023 was $158 million, according to the original deal press release from September 23, 2024. It is based in Miramar, Florida. Telix is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals. Telix... Read More »
Flourish Research Receives Strategic Majority Investment from Genstar Capital
Flourish Research has announced a strategic majority investment from San Francisco, California-based Genstar Capital. Based in New York City, Flourish Research is a fully integrated clinical trial organization in North America. The company has sites throughout Alabama, California, Florida, Illinois, North Carolina, Pennsylvania and Texas. Flourish’s network of 24 sites and 150 investigators conducts studies spanning all phases of clinical trial research. Flourish Research was formed in 2021 by New York-based private equity firm NMS Capital. Genstar Capital is a private equity investment firm that makes leveraged investments in middle-market companies. Genstar has approximately $49... Read More »
SubjectWell Buys Digital Patient Recruitment Provider Trials24
SubjectWell has announced its acquisition of Trials24, a provider of global digital patient recruitment solutions. This marks SubjectWell’s first acquisition announcement since it was acquired by New York-based private equity firm WindRose Health Investors in April 2024. Trials24 is a patient recruitment provider that assists biopharmaceutical companies and contract research organizations in completing clinical trials on time. It offers cutting-edge technology, digital marketing expertise, and an engagement center with local native-language representatives in more than 13 European countries. SubjectWell is a patient access marketplace that connects patients with chronic health conditions... Read More »
Northwest Urgent Care to Acquire 10 Carbon Health Urgent Care Centers in Arizona
Northwest Urgent Care, LLC, a Tucson, Arizona-based subsidiary of Community Health Systems, Inc., has signed an agreement to acquire 10 Arizona urgent care centers. The urgent care centers are being acquired from Carbon Health, an American chain of primary healthcare and urgent care clinics that also provides telemedicine. Northwest Urgent Care is part of Northwest Healthcare, an integrated network serving Tucson and nearby communities. Northwest Healthcare offers a full range of services, from specialized cardiac and surgical care to routine primary care, ensuring accessible, high-quality healthcare. The acquisition will expand capacity and increase Northwest Healthcare’s network to more... Read More »
PharmaLegacy Acquires Preclinical CRO BTS Research
PharmaLegacy Laboratories announced on September 16 that it acquired BTS Research, a San Diego, California-based contract research organization (CRO). BTS Research (formerly BioTox Sciences) delivers GLP and Non-GLP biological services to clients in pharmaceutical, biopharmaceutical, biotech, academic research, medical device and related industries. The CRO was founded in 2007 and acquired Bio-Quant in 2011. PharmaLegacy Laboratories is a CRO founded in 2008 which provides efficient and cost-effective preclinical in vitro and in vivo pharmacology studies to life science organizations. PharmaLegacy boasts a thousand of validated in vitro and in vivo services across more than 40 different... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
